HopeStage
Back to all studies
Not Yet RecruitingNCT07326124

Stratification and Treatment in Early Psychosis Study -ASSIST

Medication studyAges 16–50Multiple countriesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 16 years to 50 years.

Listed locations
Berlin and 14 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: January 2027
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
250
Sponsor
University of Oxford
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United Kingdom, Switzerland, Germany, ...
Age range
From 16 Years to 50 Years
Official registry ID
NCT07326124
Official title
Show the full official title

Full Title: Cannabidiol Augmentation of Clozapine in Treatment Resistant Psychosis: a Double-blind, Randomised Controlled Trial

Recruitment & locations

Not yet recruiting

Berlin, Germany · Cologne, Germany · Munich, Germany

12 more locations
  • Athens, Greece
  • Hod HaSharon, Israel
  • Petah Tikva, Israel
  • Ramat Gan, Israel
  • Naples, Italy
  • Amsterdam, Netherlands
  • Madrid, Spain
  • Seville, Spain
  • Zurich, Switzerland
  • Cambridge, United Kingdom
  • London, United Kingdom
  • Oxford, United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Oxford, a university.

Does this study involve medication?

Yes. The study involves medication, including CBD 100 mg/mL Oral Solution and Placeb.

Who can participate?

Listed age limits: 16 years to 50 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies